FDA Calendar


Company Name NPS Pharmaceuticals Inc
Drug Name Gattex (NDA)
Event Name FDA decision on Gattex for proposed treatment of adult short bowel syndrome
Event Date 09/30/2012
Outcome FDA decision date postponed to Dec.30, 2012
Drug Status
Rival Drugs
Market Potential
Other Approvals
News
NPS Pharma Says FDA Accepts NDA For GATTEX For Adult Short Bowel Syndrome
NPS Pharma - A Walkthrough
NPS Pharma Says FDA Extends PDUFA Action Date For Gattex By 3 Months
Return to FDA Calendar